13073_2018_601_MOESM5_ESM.xlsx (25.92 kB)
Additional file 5: of Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations
dataset
posted on 2018-11-29, 05:00 authored by Elen Höglander, Silje Nord, David Wedge, Ole Lingjærde, Laxmi Silwal-Pandit, Hedda Gythfeldt, Hans Vollan, Thomas Fleischer, Marit Krohn, Ellen Schlitchting, Elin Borgen, Øystein Garred, Marit Holmen, Erik Wist, Bjørn Naume, Peter Van Loo, Anne-Lise Børresen-Dale, Olav Engebraaten, Vessela KristensenTable S4. Aberrant genes in > 30% of the samples at week 25 within the Combination arm. (XLSX 25 kb)
